Level III new opioid of the Word Health Organization;Nouveaux antalgiques de niveau III de l'Organisation mondiale de la santé

Revue de Medecine Interne

Volumn 23, Issue 1, 2002, Pages 55-70

  Laval, G ^a   Sang, B ^a   Mallaret, M ^a   Villard, M L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Opioids; Pain; Pharmacology; Prescription

Indexed keywords

ACTISKENAN; BUPRENORPHINE; CODEINE; CODENFAN; DANTRON; DEXTROPROPOXYPHENE; DICODIN; DIHYDROCODEINE; DUROGESIC PATCH; FENTANYL; FENTANYL CITRATE; HYDROMORPHONE; JAMYLENE; LACTULOSE; MACROGOL; MACROGOL 3350; MACROGOL 4000; METHADONE; MORPHINE; MORPHINE SULFATE; NALBUPHINE; NALOXONE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE; SENOKOT; SORBITOL; TRAMADOL; UNCLASSIFIED DRUG; ZAMUDOL;

ANALGESIA; ARTICLE; CANCER PAIN; CONSTIPATION; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; HUMAN; PAIN; PHARMACOKINETICS; PRESCRIPTION; SIDE EFFECT; SUBMUCOSA;

EID: 0036145251     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00515-X     Document Type: Short Survey

References (45)

1. Analgésiques: Principes et règles d'utilisation, posologies de la morphine et de ses dérivés
2. Données physiopathologiques concernant les douleur et les antalgiques
3. Douleurs neurologiques, douleurs par déafférentation périphérique et douleurs neurologiques centrales
4. Effets antalgiques des antidépresseurs
5. Place des psychotropes (neuroleptiques, antiépileptiques, tranquilisants, hypnotiques, bêtabloquants, antiparkinsonniens, lithium) dans le traitement de certaines douleurs
6. Randomized placebo-controlled trial of the activity of the morphine glucuronides
7. Quand la morphine orale ne permet plus de contrôler la douleur: La rotation des opioïdes
8. Pharmacologie des morphiniques: Voie orale et transdermique
9. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine
10. The analgesic effects of morphine 6-glucuronide
11. Transdermal fentanyl: Clinical pharmacology
12. Durogesic, premier antalgique majeur transdermique
13. Fentanyl pharmacokinetics in anesthetized patients with cirrhosis
14. Renal failure, surgery and fentanyl pharmacokinetics
15. L'utilisation du fentanyl par voie transdermique pour traiter les accès de douleur paroxystique
16. Hydromorphone CME
17. A randomised cross-over comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain
18. The central and peripheral influences of opioids on gastrointestinal propulsion
19. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot plate analgesia in the mouse
20. Contrôle de la constipation morphino-induite
21. Oral naloxone treatment of narcotic induced constipation dose response
22. Role of opiate receptors in the regulation of colonic transit
23. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy and quality of life. The TTS fentanyl comparative trial group
24. Transdermal fentanyl in cancer pain
25. Direct conversion from oral morphine to transdermal fentanyl: A multicenter study in patients with cancer pain
26. Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine
27. Opioid analgesic and narcotic antagonists
28. Morphine: Ne pas en avoir peur
29. Rotation d'opioïdes
30. Pharmacological mechanisms of opioid analgesics
31. What's all the RAVE about receptor internalization?
32. Opioid in non malignant pain: Questions in search of anowers
33. Practice guidelines for chronic pain management A report by the American Society of Anesthesiologists. Task force on pain management, chronic pain section
34. The use of opioids for the treatment of chronic pain: A consensus statement
35. Morphine in cancer pain modes of administration
36. Morphine and alternative opioids in cancer pain: The EAPC recommendations
37. Utilisation de la morphine dans les douleurs rhumatologiques non cancéreuses: Les recommandations de Limoges
38. Randomised trial of oral morphine for chronic non cancer pain
39. Opioid therapy for chronic non cancer back pain
40. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in non malignant pain
41. Évaluation et suivi de la douleur chronique chez l'adulte en médecine ambulatoire
42. Opioid rotation for toxicity reduction in terminal cancer patients
43. Opioid analgesics and antagonists
44. Analgésiques opioïdes et leurs antagonistes